Incidence of cervical disease associated to HPV in human immunodeficiency infected women under highly active antiretroviral therapy

Table 6 Incidence of risk factors on cervical disease in HIV infected women under treatment (HAART) and those without treatment or HAART initiation

	LSIL			HSIL			Mann-Withney test
Groups	n	%	Mean ± SE	n	%	Mean ± SE
Age at first vaginal sex (years)
<15	03	17.6	13.7 ± 0.3	06	27.3	13.2 ± 0.3	0.381 ns
15 – 18	10	58.8	16.5 ± 0.5	11	50.0	16.4 ± 0.3	0.860 ns
≥ 19	04	23.5	19.8 ± 0.5	05	22.7	20.2 ± 0.7	0.905 ns
Total	17	-	16.8 ± 0.5	22	-	16.4 ± 0.6	0.571 ns
Pregnancy
≤ 4	13	76.4	2.4 ± 0.3	10	45.5	2.8 ± 0.3	0.420 ns
5–9	02	11.8	5.5 ± 0.5	10	45.5	1.4 ± 0.4	0.590 ns
≥ 10	02	11.8	11.5 ± 0.5	02	09.0	0.7 ± 0.5	0.333 ns
Total	17	-	3.8 ± 0.8	22	-	5.1 ± 0.6	0.068 ns
Abortion
0	03	17.6	0.0 ± 0.0	06	27.3	0.0 ± 0.0	-
1–2	12	70.6	1.3 ± 0.3	08	36.4	1.4 ± 0.2	0.669 ns
> 2	02	11.7	3.0 ± 0.0	08	36.4	3.6 ± 0.3	0.400 ns
Total	17	-	1.24 ± 0.2	22	-	1.8 ± 0.3	0.372 ns

ISSN: 1750-9378